What now for the amyloid hypothesis?
The Alzheimer's disease research field has been beset by failed clinical trials and fraud. But researchers remain hopeful that a better understanding of the disease’s broader picture will lead to treatments.
Articles by Dan Samorodnitsky, PhD
A new gene therapy for inherited blindness
Neuroscientists safely delivered a critical gene that improved vision for two patients with Leber congenital amaurosis.
CAR T cells attack fungal infections
Mycologists programmed immune cells to attack Aspergillus fumigatus, a common infectious species rapidly growing resistant to antifungals.
The ecology of disease
A clear-eyed view of illness emerges from Alzheimer's disease.
Algae microrobots fight persistent bacterial infections
Bioengineers used a modular, step-by-step chemical technique to create algae that carry antibiotic payloads.
A vaccine against heroin overdose
After decades of research, chemists created antibodies that could help patients fight addiction.
A potential target for treating preeclampsia
By studying the metabolic pathways that go awry in the placenta, scientists found a molecule that restores normal cellular function in preeclampsia.
Stem cells ease lung transplant rejection
A transfusion of mesenchymal stem cells stabilized and, in some cases, improved transplanted lung function in patients with chronic organ rejection.
An extra sticky mussel-inspired skin graft heals without scars
To avoid the pain, scars, and complications of traditional skin grafts and sutures, scientists take inspiration from mussels, some of the stickiest, most resilient animals on Earth.
A gene therapy for food allergies
Exposing mice to ovalbumin using a viral vector protected mice from anaphylaxis and abolished existing egg allergies.
